Drug Profile
GSK 565154
Alternative Names: 565154; GSK-565154Latest Information Update: 28 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Protein 50S ribosomal subunit inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Respiratory tract infections
Most Recent Events
- 25 Jan 2008 Discontinued - Phase-I for Respiratory tract infections in United Kingdom (PO)
- 31 Dec 2004 Phase-I clinical trials in Respiratory tract infections in United Kingdom (PO)